Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 1 December 1972:
Vol. 178. no. 4064, pp. 984 - 986
DOI: 10.1126/science.178.4064.984
Prev | Table of Contents | Next

Articles

Blood-Brain Barrier: Penetration of Morphine, Codeine, Heroin, and Methadone after Carotid Injection

W. H. Oldendorf 1, S. Hyman 1, L. Braun 1, and S. Z. Oldendorf 1

1 Department of Neurology, Reed Neurological Research Center, School of Medicine, University of California, Los Angeles 90024, and Neurology and Research Services, Veterans Administration, Wadsworth Hospital Center, Los Angeles, California 90024

Labeled morphine, codeine, heroin, or methadone was injected as a bolus into the common carotid artery of the rat, and the rat was decapitated 15 seconds later. The brain uptake of the drug was calculated by measurement of the brain content of the drug as a percentage of a labeled, highly diffusible reference substance simultaneously injected. The uptake of morphine was below measurability; the uptake of codeine was 24 percent; heroin, 68 percent; and methadone, 42 percent. Brain uptakes of morphine and codeine were also studied after intravenous injection and correlated well with uptakes after carotid injection; the uptake of codeine being nearly complete by 30 seconds. These studies indicate that brain uptake of certain of these drugs is very rapid and that uptake of heroin injected intravenously is probably limited by the regional flow of blood in the brain. The possible relation of this rapid penetration of the blood-brain barrier by heroin to its strongly addictive properties is discussed.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Increased Locomotor Activity Induced by Heroin in Mice: Pharmacokinetic Demonstration of Heroin Acting as a Prodrug for the Mediator 6-Monoacetylmorphine in Vivo.
J. M. Andersen, A. Ripel, F. Boix, P. T. Normann, and J. Morland (2009)
J. Pharmacol. Exp. Ther. 331, 153-161
   Abstract »    Full Text »    PDF »
Evidence for the Nucleus Accumbens as a Neural Substrate of Heroin-Induced Immune Alterations.
T. B. Saurer, S. G. Ijames, and D. T. Lysle (2009)
J. Pharmacol. Exp. Ther. 329, 1040-1047
   Abstract »    Full Text »    PDF »
Codeine phosphate in paediatric medicine.
D. G. Williams, D. J. Hatch, and R. F. Howard (2001)
Br. J. Anaesth. 86, 413-421
   Abstract »    Full Text »    PDF »
Morphine Tolerance in Mice Changes Response of Heroin from {micro} to {delta} Opioid Receptors.
J. J. Rady, B. B. Holmes, P. S. Portoghese, and J. M. Fujimoto (2000)
Experimental Biology and Medicine 224, 93-101
   Abstract »    Full Text »
Effects of a Potent and Specific P-Glycoprotein Inhibitor on the Blood-Brain Barrier Distribution and Antinociceptive Effect of Morphine in the Rat.
S. P. Letrent, G. M. Pollack, K. R. Brouwer, and K. L.R. Brouwer (1999)
Drug Metab. Dispos. 27, 827-834
   Abstract »    Full Text »
Acute Heroin Overdose.
K. A. Sporer (1999)
Ann Intern Med 130, 584-590
   Abstract »    Full Text »    PDF »
Blood-Brain Barrier Permeability to Morphine-6-Glucuronide is Markedly Reduced Compared with Morphine.
D. Wu, Y.-S. Kang, U. Bickel, and W. M. Pardridge (1997)
Drug Metab. Dispos. 25, 768-771
   Abstract »    Full Text »
Opioid Modulation of the Fetal Hypothalamic-Pituitary-Adrenal Axis: The Role of Receptor Subtypes and Route of Administration.
C. C. Taylor, D. Wu, Y. Soong, J. S. Yee, and H. H. Szeto (1997)
J. Pharmacol. Exp. Ther. 281, 129-135
   Abstract »    Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)